Brief: Theranexus End-Sept Cash Position At 12.5 Million Euros
19/10/2021 17:17
Oct 19 (Reuters) - Theranexus SA ALTHX.PA :
* TOTAL AVAILABLE FUNDS ON 30 SEPTEMBER 2021 STOOD AT €12.5
M,
COMPARED WITH €13.5 M ON 30 JUNE 2021
* COMPANY SHOULD ALSO BENEFIT FROM THE 2020 RESEARCH TAX
CREDIT
(CIR) FOR A SUM OF €1.0 M,
Source text for Eikon: ID:nACT71556
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease